PATENT CLAIM ANALYSIS

Application Number: 16014233
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "218000"]

Abstract:
The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of JAK kinases. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat gastrointestinal and other inflammatory diseases, and processes and intermediates useful for preparing such compounds.

Claim (Index 14):
The crystalline form of  claim 12 , wherein the crystalline form is characterized by a powder X-ray diffraction pattern in which the peak positions are substantially in accordance with the peak positions of the pattern shown in  FIG. 1 .

Metadata:
- Claim Count in Document: 56.0
- Percentile: 94.0
- Lexical Diversity: 1.38298
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15631220', '15498803', '15165126', '13592389', '15966467']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578016392650699
- 35 USC 102 Novelty (BERT): 0.5574934240453758
- Combined Prediction Score: 0.7377708177431005
- Mean Citation Score: 318.4804180000001
- Max Citation Score: 419.70132
- Similarity Product: 305.61882899152283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test